Journals / Van Sağlık Bilimleri Dergisi / 2006 / Cilt: 9 Sayı: 1

Investigation of Effects on the Henıatological Parameters and Aorta of Simvastatin and Amlodipin

Simvastatin ve Amlodipin'in Hematolojik Parametreler ve Aorta Üzerine Etkilerinin Araştırılması

Pages
29–38
Publication Date
2006-01-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result. the uses of simvastatin and amlodipin single and in combination caused signifıcant hematological changes in rats given drugs for six months and hematological analyses should be repeated at spesific intervals.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study hematological effects of Simvastatin and Amlodipin commonly used in developed societies were investigated.
📊
Key Findings & Data:A total of 48 rats were divided into 4 teratment groups each containing 12 and fed for six months.
💡
Conclusion & Impact:As a result. the uses of simvastatin and amlodipin single and in combination caused signifıcant hematological changes in rats given drugs for six months and hematological analyses should be repeated at spesific intervals.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Simvastatin · Amlodipin. Hematolojik. Rat. Yan etki · Simvastatin. Amlodipin. Rat. Hematologic

Abstract

In this study hematological effects of Simvastatin and Amlodipin commonly used in developed societies were investigated. Side effects were determined hematological. macroscopic and histopathological analyses by giving these drugs to rats for six months single and in combination. A total of 48 rats were divided into 4 teratment groups each containing 12 and fed for six months. Groups are Control, Simvastatin 10 mg/kg, Amlodipin 10 mg/kg and Simvastatin 10 mg/kg+Amlodipin 10 mg/kg. Control group was fed only feed and water. Other groups were treated with drugs by orally with doses above and fed with basal diet and water. Blood samples total blood celi were taken from animals on third and sixth months of the treatment and blood hematological analyses were performed. Paraleli results were obtained in hematological analyses Hb Hemoglobin . Ht Hematocrit . MCHC Mean corpuscular hemoglobin consantration , RBC Red blood celi , WBC White blood celi . MCV Mean corpuscular volüme . MCH Mean corpuscular hemoglobin . Thromb Trombocyt and LY Lymphocvt between 3rd and 6,h months of the experiment compared to control. Hb. Ht. and MCHC values were observed higher than control. while RBC, WBC. MCV. MCH. Thromb and LY values were decreased in drugs treated groups Simvastatin. Amlodipin. Simvastatin plus Amlodipin . As a result. the uses of simvastatin and amlodipin single and in combination caused signifıcant hematological changes and degeneration in hemapoetik organs in rats given drugs for six months. At the end of the treatment eight animals were killed for makroskobik and histopathological analyses and aorta samples were analysed microscobically. However, especially. simvastatin can cause antiinflamatuar effects and prevent intimal thickening in aorta samples. but in our study there is no microscobic and histopathologic fındings. As a result. the uses of simvastatin and amlodipin single and in combination caused signifıcant hematological changes in rats given drugs for six months and hematological analyses should be repeated at spesific intervals.

Özet

Bu çalışmada, modern toplumlarda sık olarak karşılaşılan hastalıklardan olan hiperlipidemi ve hipertansiyon durumlarında tercih edilen Simvastatinin ve Amlodipinin hematolojik parametreler ve Aort üzerine etkileri araştırıldı. Ratlara altı ay süreyle bu ilaçların verilmesiyle ortaya çıkan toksik etkiler hematolojik açıdan ve primer hedef organ olan aortanın histopatolojik analizleri ile belirlenmeye çalışıldı. Toplam 48 hayvan her gruptan 12 hayvan olacak şekilde dört deneme grubuna ayrılarak altı ay süreyle beslendi. Gruplar; Kontrol. Simvastatin lOmg/kg . Amlodipin 10 mg/kg . Simvastatin+Amlodipin Simvastatin 10 mg/kg + Amlodipin 10 mg/kg olarak belirlendi. Kontrol grubuna sadece yem ve su. diğer gruplara yem ve suya ilave olarak belirtilen dozlarda ilaçlar oral yolla verildi. Denemenin başında, üçüncü ayda ve deneme sonunda altıncı ayda her gruptan kan örnekleri alınarak hematolojik analizler RBC Alyuvar . WBC akyuvar . Hb Hemoglobin . Ht hematokrit , MCHC Ortalama eritrosit hemoglobin konsantrasyonu . Tromb. Trombosit . MCV Ortalama eritrosit hacmi . MCH Ortalama hemoglobin konsantrasyonu ve LY lenfosit gerçekleştirildi. Deneme sonunda her gruptan 8 hayvana otopsi uygulanarak aort makroskobik ve histopatolojik olarak incelendi. Hematolojik analizlerde üçüncü ve altıncı ayda yapılan ölçümler arasında paralel değerler elde edildi. Kontrolle karşılaşıldığında ilaç uygulanan tüm gruplarda Simvastatin. Amlodipin, Simvastatin + Amlodipin RBC. WBC. Hb. Ht. MCHC. Tromb. düzeylerinde artış görülürken. MCV. MCH ve LY düzeylerinde ise anlamlı düşüş gözlendi. Aorta örneklerinin makroskobik ve mikroskobik incelenmesi sonucunda ilaç uygulanan tüm gruplarla kontrol grubu arasında her hangi bir farklılık bulunmadı. Sonuç olarak, simvastatin ve amlodipinin yalnız ve kombine olarak ratlara altı ay süreyle verilmesi anlamlı hematolojik değişiklikler yapabilmesi ve bu ilaçların uzun süreli kullanım gerektirmeleri nedeniyle, klinik çalışmalarla da desteklenmesi gerekmektedir

🔖

Cite This Article

GÜLTEKİN, C., RAĞBETLİ, M. Ç., ERDOĞAN, E., CENGİZ, N. (2006). Investigation of Effects on the Henıatological Parameters and Aorta of Simvastatin and Amlodipin. Van Sağlık Bilimleri Dergisi, Cilt: 9 Sayı: 1, 29–38. https://ajindex.com/articles/947713

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Ziversmit DB (1979) Atherogenesis: a postprandalphenemon,Cic\A 2. Marz W. Wollschlager II. Klein G, Nei BA and Wehling M (1999) Koroner kalp hastalığı bulunan bir hastapopulasyonıında siınvastatin ile karşılaştırmalı olarak atorvastatin ile sağlanan düşük dansiteli lipoprotein kolesterol düşürücü tedavinin güvenirliği (TARGET TANGİBLE Çalışması). The American Journal of Cardiology. 1999. Julv 1.84.1 -8 3. Isusi E. Aspichueta P. Liza M. Hernandez LM. Diaz C. Hernandez G and et ali (2000) Short and long ter m effects ofatorvastatin. lovaslatin and simvastatin on the cellular melabolisnı of cholesteryl eslers and VLDL secretion in hepotocytes, Atherosclerosis, 2000. 153. 283- 294. 4. Karaca I. Akbulut M, İlkay E. Üstündağ B, Özbay Y ve Arslan N (1999) Hiperlipidemik hastalarda simvastatinin etkinliği ve güvenirliği. T Klin Kardiyoloji 1999. 12. 100- 103. 5. Kayaalp O (2000a) Antihipertansif İlaçlar In “Rasyonel Tedavi Yönünden Tıbbi Farmakoloji ” Ed. by Hacettepe TAŞ Kitapçılık Ltd Şti, 1. cilt. 8. baskı 423-471 6. Çalışkan S, Çalışkan M. Kuralay F and Onvural B (2000) Effects of simvastatin therapy on blood and tissııe ATP /eveIs and erythrocyte membrane lipid composition. Res Exp Med(Berl), 2000. Feb, 199 (4), 189-194. 7. Sharifı AM and Schiffrin EL (1998) Apoptosis in vaskulatııre of spontaneoıısly hypertansive rats effect of an angiotensin converting emzyme inhihitor and a calcium channel antagorıist, American Journal of Hypertansion. 11. 1108- 1116. 8. Sparrow CP. Burton CA. Flernandez M. Mundt S, Hassing H, Patel S and et ali (2001) Simvastatin has anti-inflamatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler Thromb Vasc Biol. 21, 115- 121. 9. Mital S, Magneson A, Lake KE, Liao J. Forfıa PR and Ilintze TH (2000) Simvastatin actssynergistically with ACE inhibitors or amlodipine to decrease oxvgen consumption in rat hearts. J Cardiovasc Phannacol. 2000. Aug. 36 (2). 248-254. 10. Suzuki M. Yamanaka K. Nabata H and Tachibana M (1993) Long terin effects of aınlodipine on organ damage. stroke and life span in stroke prone spontaneously hypertensive rat s. Eur J Phannacol. Aprl. 228 (5-6). 269-274. 1!. Khemissa-Akouz F, Ouguergouz F. Şulem P. Tkoub el M and Vaucher E (2002) Amlodipine induced acııte hepatitis. Gastroenterol Clin Biol. Jun-Jul. 26 (6-7). 637-638. 12. KanathurN. Mathai MG. Bvrd RPJr. Fields CL and Roy TM (.2001) Simvastatin-diltiazem drııg interaction safely resulting in rhabdomyolysis and hepati